Table of Contents
1. Market Overview
1.1 Product Overview and Scope of Market
1.2 Global Market of Viral Vector Development Service
2. Market Insights by Product Type
2.1 Market Revenue by Product Types:
2.1.1 Table Market Revenue (in million USD) by Product Types (Historic Data)
2.1.2 Graph Market Revenue ( in million USD) by Product Types (Current & Forecast Data)
2.1.3 Graph Market Share (%) by Product Types in 2018
2.2 Market Volume by Product Types:
2.2.1 Table Market Volume (in million Units) by Product Types (Historic Data)
2.2.2 Graph Market Volume ( in million Units) by Product Types (Current & Forecast Data)
2.2.3 Graph Market Share (%) by Product Types in 2018
2.3 Retroviral Vectors Market Analysis
2.3.1 Graph Global Retroviral Vectors Market Revenue (in million USD ) (2018-26)
2.3.2 Graph Global Retroviral Vectors Market Volume (in million units ) (2018-26)
2.3.3 Table Retroviral Vectors Market Geographical Analysis
2.4 Lentiviral Vectors Market Analysis
2.4.1 Graph Lentiviral Vectors Market Revenue (in million USD) (2018-26)
2.4.2 Graph Global Lentiviral Vectors Market Volume (in million Units ) (2018-26)
2.4.3 Table Lentiviral Vectors Market Geographical Analysis
2.5 Adenoviral Vectors
2.6 Adeno-associated Viral Vectors
3. Market Segment by Applications
• Pharmaceutical Manufacturers
• Biotechnology Companies
• Research Institutes
3.1 Table Market Revenue (in million USD) by Application (Historic Data)
3.2 Table Market Revenue (in million USD) by Application (Current & Forecast Data)
3.3 Pharmaceutical Manufacturers application/ end user analysis
3.3.1 Graph Global Pharmaceutical Manufacturers Revenue (in million USD ) (2018-26)
3.3.2 Table Global Pharmaceutical Manufacturers Geographical Analysis
3.4 Biotechnology Companies
3.4.1 Graph Global Biotechnology Companies Revenue (in million USD ) (2018-26)
3.4.2 Table Global Biotechnology Companies Geographical Analysis
3.5 Research Institutes
4. Regional Market Analysis
4.1.1 Global Market Revenue (In Million) and Growth Rate Comparison by Regions (2018-2026)
4.1. North America Viral Vector Development Service Market Analysis(2018-26)
4.1.1 USA
4.1.2 Canada
4.1.3 Mexico
4.2 Europe Viral Vector Development Service Market Revenue Forecast (2018-27)
4.2.1 UK
4.2.2 Germany
4.2.3 France
4.2.4 Italy
4.2.5 Rest Of Europe
4.3 APAC Viral Vector Development Service Market Revenue Forecast (2018- 2026)
4.3.1 China
4.3.2 Japan
4.3.3 India
4.3.4 Singapore
4.3.5 Malaysia
4.3.6 Rest Of APAC
4.4 Rest Of the World (ROW) Market Revenue Forecast (2018-2026)
4.4.1 Africa
4.4.2 Middle East
4.4.3 South America
5. Competitive Analysis
5.1 Kaneka Eurogentec
5.1.1 Overview :
5.1.2 Basic Company Information:
5.1.3 Financial Overview
5.1.3 Production Overview
5.1.4 Geography Revenue Mix ( 2018)
5.1.5Business Revenue Mix
5.1.6 Recent Development
5.2 FinVector
5.2.1 Overview :
5.2.2 Basic Company Information:
5.2.3 Financial Overview
5.2.4 Production Overview
5.2.5 Geography Revenue Mix ( 2018)
5.2.6 Business Revenue Mix
5.2.7 Recent Development
• Brammer Bio
• Cell and Gene Therapy Catapult
• FUJIFILM Diosynth Biotechnologies
• Sanofi
• Spark Therapeutics
• Cobra Biologics
• UniQure and MassBiologics
• Renova Therapeutics
• Shenzhen SiBiono GeneTech
• Thermo Fisher Scientific
6. Research Findings and Conclusion
6.1 Research Finding:
6.2 Conclusion:
7. Methodology and Data Source
7.1 Methodology/Research Approach
7.2 Research Programs/Design
7.3 Market Size Estimation
7.4 Market Breakdown and Data Triangulation
7.5 Data Source
7.5.1 Secondary Sources
7.5.2 Primary Sources
7.6 Disclaimer